Roles of the Receptor for Advanced Glycation End Products and Its Ligands in the Pathogenesis of Alzheimer’s Disease
Top Cited Papers
Open Access
- 5 January 2025
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (1) , 403
Abstract
The Receptor for Advanced Glycation End Products (RAGE), part of the immunoglobulin superfamily, plays a significant role in various essential functions under both normal and pathological conditions, especially in the progression of Alzheimer’s disease (AD). RAGE engages with several damage-associated molecular patterns (DAMPs), including advanced glycation end products (AGEs), beta-amyloid peptide (Aβ), high mobility group box 1 (HMGB1), and S100 calcium-binding proteins. This interaction impairs the brain’s ability to clear Aβ, resulting in increased Aβ accumulation, neuronal injury, and mitochondrial dysfunction. This further promotes inflammatory responses and oxidative stress, ultimately leading to a range of age-related diseases. Given RAGE’s significant role in AD, inhibitors that target RAGE and its ligands hold promise as new strategies for treating AD, offering new possibilities for alleviating and treating this serious neurodegenerative disease. This article reviews the various pathogenic mechanisms of AD and summarizes the literature on the interaction between RAGE and its ligands in various AD-related pathological processes, with a particular focus on the evidence and mechanisms by which RAGE interactions with AGEs, HMGB1, Aβ, and S100 proteins induce cognitive impairment in AD. Furthermore, the article discusses the principles of action of RAGE inhibitors and inhibitors targeting RAGE-ligand interactions, along with relevant clinical trials.Keywords
Funding Information
- National Natural Science Foundation of China (82174345, 2024MS167, QJRC2022033, [2022]76, S202410633056)
- General Project of the Sichuan Provincial Administration of Traditional Chinese Medicine (82174345, 2024MS167, QJRC2022033, [2022]76, S202410633056)
- Chengdu University of Traditional Chinese Medicine—Xinglin Scholar Program (82174345, 2024MS167, QJRC2022033, [2022]76, S202410633056)
- Seventh Batch of the National TCM Expert Academic Experience Inheritance Project (82174345, 2024MS167, QJRC2022033, [2022]76, S202410633056)
- Undergraduate Innovation and Entrepreneurship Program (82174345, 2024MS167, QJRC2022033, [2022]76, S202410633056)
This publication has 202 references indexed in Scilit:
- Cornuside, by regulating the AGEs‐RAGE‐IκBα‐ERK1/2 signaling pathway, ameliorates cognitive impairment associated with brain agingPhytotherapy Research, 2023
- The role of mitochondrial dysfunction in Alzheimer's disease pathogenesisAlzheimer's & Dementia, 2022
- Effects of RAGE inhibition on the progression of the disease in hSOD1G93A ALS micePharmacology Research & Perspectives, 2020
- RAGE in the pathophysiology of skeletal muscleJournal of Cachexia, Sarcopenia and Muscle, 2018
- Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse modelGlia, 2016
- Increase in production of matrix metalloproteinase 13 by human articular chondrocytes due to stimulation with S100A4: Role of the receptor for advanced glycation end productsArthritis & Rheumatism, 2006
- Role of intracellular S100A4 for migration of rat astrocytesGlia, 2005
- S100B causes apoptosis in a myoblast cell line in a RAGE‐independent mannerJournal of Cellular Physiology, 2003
- Alzheimer DiseaseJAMA, 2002
- Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1.The EMBO Journal, 1991